Breast Cancer Clinical Trials in New York

Showing 101-120 of 718 trials

A Study of Changes in Ki67 Expression in People With Breast Cancer Receiving Endocrine Therapy Before Surgery

NCT06127979

The researchers are doing this study to look at changes in Ki67 expression after at least 2 weeks of endocrine therapy in people with ER+/HER2- breast cancer undergoing cancer removal surgery. Participants will receive the endocrine therapy before their surgery. The researchers will look at how changes in Ki67 expression compare between participants who are carriers of the BRCA2 mutation and participants who are noncarriers of the BRCA2 mutation.

Breast Cancer

Memorial Sloan Kettering Cancer Center42 participantsStarted Nov 2023

New York, New York, United States

Active Not RecruitingPhase 1/2< 1 mile

Study of AZD5305 as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Malignancies

NCT04644068

This research is designed to determine if experimental treatment with PARP inhibitor, AZD5305, alone, or in combination with anti-cancer agents is safe, tolerable, and has anti-cancer activity in patients with advanced solid tumors.

Ovarian CancerBreast CancerPancreatic Cancer+10 more

AstraZeneca702 participantsStarted Nov 2020

Boston, Massachusetts, United States • Boston, Massachusetts, United States • New York, New York, United States +65 more locations

A Study of Changes in Ki67 Expression in People With Breast Cancer Receiving Endocrine Therapy Before Surgery

Study of AZD5305 as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Malignancies

Breast Cancer Trials in Other Cities

ATOP TRIAL: T-DM1 in HER2 Positive Breast Cancer

A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation

A Study of Tucatinib Given Before Surgery to People With HER2+ Cancers That Have Spread to the Brain

A Study of an Alternative Treatment Approach (Preoperative Radiotherapy, Then Mastectomy, Then Immediate Reconstruction Surgery) in People With T4 Breast Cancer

S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer

Suppression of Ovarian Function With Either Tamoxifen or Exemestane Compared With Tamoxifen Alone in Treating Premenopausal Women With Hormone-Responsive Breast Cancer

A Study of Breast Cancer Risk Factors and Outcomes of People in Florida

Group Interventions for Breast Cancer Survivors

Randomized Study of Stereotactic Body Radiation Therapy (SBRT) in Patients With Oligoprogressive Metastatic Cancers of the Breast and Lung

Exercise, Fitness and Tumor Profiling in Breast Cancer Patients

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

EUREKA Study:Phase 2 Study to Optimize Neoadjuvant Therapy in HER2-positive Early-stage Breast Cancer

A Phase 1/2 Trial of ARV-471 Alone and in Combination With Palbociclib (IBRANCE®) in Patients With ER+/HER2- Locally Advanced or Metastatic Breast Cancer

A Study of MGC026 in Participants With Advanced Solid Tumors

Patient Reported Outcomes, Smart Pill Bottle and Teleheath for Endocrine Therapy Adherence

A Study of Abemaciclib (LY2835219) Plus Tamoxifen or Abemaciclib Alone in Women With Metastatic Breast Cancer

Increasing Patients' Engagement in Breast Cancer Surgery Decision-Making

Intraoperative Electron Beam Radiotherapy Boost in Treating Patients With Stage I-II Breast Cancer Undergoing Surgery With Reconstruction

Other Conditions in New York